inverness medical innovations , page-4

I agree Ed completely but once SBN gains traction in a sales revenue sense and is perceived as such (and begins to impact the market share of larger players), it becomes a fait accompli in respect to the actions of these more predatory companies like Inverness- they are afterall by nature, an acquisitional company (one that buys revenue streams and market share) but the flipside to this is that they also provide the potential exit strategy for minnows such as SBN, of course at a price many multiples of where they currently sit! It is worth considering that in this sort of industry, small companies rarely ever get the chance to become large!

ciao